Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.53 USD | +2.00% |
|
-10.53% | -16.85% |
05-21 | Biodesix, Inc. to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting | CI |
05-13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.85% | 222M | |
-18.02% | 8.43B | |
+69.46% | 4.35B | |
+7.88% | 2.78B | |
-56.54% | 1.74B | |
-14.28% | 1.77B | |
-16.69% | 1.48B | |
+17.87% | 1.22B | |
-49.60% | 1.02B | |
-21.78% | 948M |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Earnings Flash (BDSX) BIODESIX Posts Q4 Revenue $14.7M